Arvinas, Inc. (ARVN)
13.10
-0.22
(-1.61%)
USD |
NASDAQ |
Dec 09, 16:00
13.10
0.00 (0.00%)
After-Hours: 16:52
Arvinas Shareholders Equity (Quarterly): 564.40M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 92.80B |
| Assembly Biosciences, Inc. | 182.70M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Verastem, Inc. | -15.53M |
| Sarepta Therapeutics, Inc. | 1.320B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 844.30M |
| Total Liabilities (Quarterly) | 279.90M |
| Debt to Equity Ratio | 0.0168 |
| Current Ratio | 5.703 |
| Net Debt Paydown Yield | -0.24% |